The market for treating vaginal and vulval inflammatory diseases is expected to reach US$ 2.96 billion in fiscal year 2023, up from US$ 2.8 billion in fiscal year 2022. The global market is expected to grow steadily at a 5.8% CAGR between 2023 and 2033, reaching a value of US$ 5.21 billion by the end of that year.

Among the symptoms of vaginal and vulval inflammation are swelling around the vagina, heat when urinating, whitish-gray vaginal discharge, and clumpy vaginal discharge. Candidiasis, a yeast infection, can irritate the vaginal lining. A healthy vagina is made up of bacteria and a small number of yeast cells, but when the ratio of bacteria to yeast changes, these yeast cells or other microorganisms have the potential to grow, causing swelling, acute stinging, and irritation.

According to CDC estimates, 42%-45% of women may experience this illness twice or more per year, and approximately three-fourths of women are expected to develop vaginal and vulval inflammation at least once. This condition is classified as difficult or simple based on its clinical presentation, host characteristics, and response to therapy.

Contacting a gynaecologist or a nurse practitioner is frequently required. Antifungal medications can also be used to treat vaginal and vulval irritation. While most cases of vaginal and vulval inflammation can be treated in a few days, more severe cases may require longer treatment. Over the forecasted period, such factors have increased the demand for treatments for vaginal and vulval inflammations.

Competitive Landscape

Some of the top players in the global Parkison’s disease market are:

  • Almirall
  • VenusConcept
  • ThermiGen LLC
  • Lutronic
  • BTL Group of Companies
  • Viveve
  • Fotona
  • Evofem Biosciences, Inc.
  • Spero Therapeutics
  • Hologic
  • Kyung Hee University Hospital

Browse More@ https://www.futuremarketinsights.com/reports/vaginal-and-vulval-inflammatory-treatment-market

Vaginal And Vulval Inflammatory Diseases Treatment Market By Indication:

  • Vaginal Dryness
  • Vaginal Burning
  • Vaginal Discharge
  • Genital Itching
  • Recurrent Urinary Tract Infections
  • Urinary Incontinence
  • Others

Vaginal And Vulval Inflammatory Diseases Treatment Market By Treatment:

  • Anti-Itch Medications
  • Corticosteroid Ointments
  • Anti-Itch Emollients

Vaginal And Vulval Inflammatory Diseases Treatment Market By End User:

  • Hospital Pharmacies
  • Specialty Clinics
  • Others